igeahub.com
European Commission Approves Once-Daily Olumiant Tablets for Treating Adults with Moderate-to-Severe Active Rheumatoid Arthritis - IgeaHub
Feb. 13, 2017 Eli Lilly and Company and Incyte Corporation have announced that the European Commission has granted marketing authorisation for